Mannes M, Dopler A, Zolk O, et al. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity. Blood. 2021;137(4):443-455

Blood. 2024 Apr 25;143(17):1783. doi: 10.1182/blood.2024024193.
No abstract available

MeSH terms

  • Complement Activation
  • Complement C3* / metabolism
  • Complement C5 / antagonists & inhibitors
  • Complement C5 / immunology
  • Humans

Substances

  • Complement C3
  • Complement C5